Recent Advances on Starch-Based Biomaterials: A Review.

IF 6.9 Q1 POLYMER SCIENCE
ACS polymers Au Pub Date : 2026-02-19 eCollection Date: 2026-04-08 DOI:10.1021/acspolymersau.5c00188
Renan N Araújo, Bruna S Bitencourt, Samile B de Aguiar, Pedro A I Sponchiado, Petrus N Kirsten, Larissa Tessaro, Ana Paula Ramos, Pedro E D Augusto, Bianca C Maniglia
{"title":"Recent Advances on Starch-Based Biomaterials: A Review.","authors":"Renan N Araújo, Bruna S Bitencourt, Samile B de Aguiar, Pedro A I Sponchiado, Petrus N Kirsten, Larissa Tessaro, Ana Paula Ramos, Pedro E D Augusto, Bianca C Maniglia","doi":"10.1021/acspolymersau.5c00188","DOIUrl":null,"url":null,"abstract":"<p><p>Starch's versatility inspires biomaterials for biomedical uses, customized through modifications, blending, or substituents. Diligent efforts have been dedicated to the development of starch-based biomaterials, leveraging the material's inherent biocompatibility and biodegradability, while aligning with environmentally sustainable considerations. While promising, most studies lack in vivo data and scalability assessments. In many cases, the reported advances are restricted to in vitro evaluations with limited information on long-term performance, clinical translation, and large-scale manufacturing feasibility in both economic and operational terms. This review furnishes an up-to-date synthesis of information available in the literature concerning recent breakthroughs in utilizing starch as a biomaterial, primarily focusing on advancements in areas such as wound dressings, drug delivery systems, the creation of scaffolds for regenerative medicine, and applications in tissue engineering. Advances have been made, with biomaterials presenting adequate biodegradability rates, active functions, good biocompatibility, and mechanical properties. However, it is noted that most research has not yet reached in vivo evaluations and lacks notions of large-scale production, in both economic and operational terms.</p>","PeriodicalId":72049,"journal":{"name":"ACS polymers Au","volume":"6 2","pages":"520-534"},"PeriodicalIF":6.9000,"publicationDate":"2026-02-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13067164/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS polymers Au","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1021/acspolymersau.5c00188","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/4/8 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"POLYMER SCIENCE","Score":null,"Total":0}
引用次数: 0

Abstract

Starch's versatility inspires biomaterials for biomedical uses, customized through modifications, blending, or substituents. Diligent efforts have been dedicated to the development of starch-based biomaterials, leveraging the material's inherent biocompatibility and biodegradability, while aligning with environmentally sustainable considerations. While promising, most studies lack in vivo data and scalability assessments. In many cases, the reported advances are restricted to in vitro evaluations with limited information on long-term performance, clinical translation, and large-scale manufacturing feasibility in both economic and operational terms. This review furnishes an up-to-date synthesis of information available in the literature concerning recent breakthroughs in utilizing starch as a biomaterial, primarily focusing on advancements in areas such as wound dressings, drug delivery systems, the creation of scaffolds for regenerative medicine, and applications in tissue engineering. Advances have been made, with biomaterials presenting adequate biodegradability rates, active functions, good biocompatibility, and mechanical properties. However, it is noted that most research has not yet reached in vivo evaluations and lacks notions of large-scale production, in both economic and operational terms.

淀粉基生物材料的研究进展
淀粉的多功能性激发了生物医学用途的生物材料,通过修改、混合或取代来定制。人们一直致力于开发淀粉基生物材料,利用材料固有的生物相容性和生物降解性,同时符合环境可持续发展的考虑。虽然有希望,但大多数研究缺乏体内数据和可扩展性评估。在许多情况下,报道的进展仅限于体外评估,在长期性能、临床转化和经济和操作方面的大规模生产可行性方面的信息有限。本文综述了淀粉作为生物材料的最新突破,主要集中在伤口敷料、药物输送系统、再生医学支架的创建以及组织工程中的应用等领域。生物材料已取得进展,具有足够的生物降解率、活性功能、良好的生物相容性和机械性能。然而,值得注意的是,大多数研究尚未达到体内评价,并且在经济和业务方面缺乏大规模生产的概念。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
2.50
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书